Talha Badar/X
Dec 11, 2024, 14:33
Talha Badar: The outcome of TP53m MDS with HMA and VEN vs HMA alone at ASH24
Talha Badar, Hematology/Oncology specialist in Mayo Clinic, shared a post on X:
“Great initiative by ASH not only printing but also placing posters! Do visit our poster looking at the outcome of TP53m MDS with HMA and VEN vs HMA alone.”
More posts featuring Talha Badar.
Dr. Talha Badar, MD, is a specialist in Hematology Oncology based in Mayo Clinic, Jacksonville, Florida. His primary areas of expertise include Leukemia, particularly Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplantation. Over his career, he has actively contributed to clinical research and clinical trials.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 11, 2024, 14:53
Dec 11, 2024, 14:33
Dec 11, 2024, 14:33
Dec 11, 2024, 14:33
Dec 11, 2024, 14:33
Dec 11, 2024, 14:33
Dec 11, 2024, 14:33
Dec 11, 2024, 13:22